IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 15.40B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 15.40B.
Overvalued
The company’s latest PE is 31.29, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 175.08M shares, decreasing 0.69% quarter-over-quarter.
Held by David G. Herro
Star Investor David G. Herro holds 11.75M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.10.